VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q57334564 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241020233150.0
008 241020nneanz||abbn n and d
035 ‎‡a (WKP)Q57334564‏
024 ‎‡a 0000-0003-4906-4227‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q57334564‏
100 0 ‎‡a María Luz García-García‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a María Luz García-García‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma‏
670 ‎‡a Author's [Celiac disease and glycogenosis]‏
670 ‎‡a Author's Clinical and Virological Characteristics of Early and Moderate Preterm Infants Readmitted With Viral Respiratory Infections‏
670 ‎‡a Author's [Clinical course and analysis of a case of congenital chloride diarrhea]‏
670 ‎‡a Author's Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma‏
670 ‎‡a Author's Considerations on antiviral treatment of suspected influenza infections in hospitalised children.‏
670 ‎‡a Author's [Diagnosis and treatment guidelines for difficult-to-control asthma in children]‏
670 ‎‡a Author's Eight Year Prospective Study of Adenoviruses Infections in Hospitalized Children. Comparison with Other Respiratory Viruses‏
670 ‎‡a Author's [Guidelines for the follow up of patients with bronchopulmonary dysplasia]‏
670 ‎‡a Author's High incidence of human bocavirus infection in children in Spain.‏
670 ‎‡a Author's Hospital admission due to respiratory viral infections in moderate preterm, late preterm and term infants during their first year of life.‏
670 ‎‡a Author's HUMAN BOCAVIRUS DETECTION IN NASOPHARYNGEAL ASPIRATES OF CHILDREN WITHOUT CLINICAL SYMPTOMS OF RESPIRATORY INFECTION‏
670 ‎‡a Author's Human bocavirus infection in a neonatal intensive care unit‏
670 ‎‡a Author's Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5‏
670 ‎‡a Author's Human metapneumovirus infections in hospitalised infants in Spain.‏
670 ‎‡a Author's Human metapnuemovirus infections in hospitalized children and comparison with other respiratory viruses. 2005-2014 prospective study‏
670 ‎‡a Author's [Human parechovirus-3 infection in a neonate with fever and suspected sepsis].‏
670 ‎‡a Author's Impact of Prematurity and Severe Viral Bronchiolitis on Asthma Development at 6-9 Years‏
670 ‎‡a Author's Infecciones respiratorias por metapneumovirus en lactantes hospitalizados‏
670 ‎‡a Author's Infecciones virales respiratorias en una cohorte de niños durante el primer año de vida y su papel en el desarrollo de sibilancias‏
670 ‎‡a Author's Infections and coinfections by respiratory human bocavirus during eight seasons in hospitalized children.‏
670 ‎‡a Author's Influenza C virus infection in children, Spain.‏
670 ‎‡a Author's [Influenza virus infections in infants aged less than two years old]‏
670 ‎‡a Author's Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma‏
670 ‎‡a Author's Oseltamivir treatment for influenza in hospitalized children without underlying diseases.‏
670 ‎‡a Author's Pandemic H1N1 influenza-associated hospitalizations in children in Madrid, Spain.‏
670 ‎‡a Author's [Parainfluenza virus type 4 infections]‏
670 ‎‡a Author's Pediatric Asthma and Viral Infection.‏
670 ‎‡a Author's Prospective study of influenza C in hospitalized children.‏
670 ‎‡a Author's Radiografía de tórax en la bronquiolitis: ¿es siempre necesaria?‏
670 ‎‡a Author's Recurrent wheezing and asthma after bocavirus bronchiolitis.‏
670 ‎‡a Author's Reply to letter of Drs Castro-Rodriguez and Rodrigo.‏
670 ‎‡a Author's Respiratory Infections by Enterovirus D68 in Outpatients and Inpatients Spanish Children‏
670 ‎‡a Author's Respiratory morbidity associated with viral respiratory infections during neonatal stage in premature infants‏
670 ‎‡a Author's Respiratory outcomes of "new" bronchopulmonary dysplasia in adolescents: A multicenter study‏
670 ‎‡a Author's Respiratory Syncytial Virus Coinfections With Rhinovirus and Human Bocavirus in Hospitalized Children.‏
670 ‎‡a Author's Role of emerging respiratory viruses in children with severe acute wheezing.‏
670 ‎‡a Author's [Role of rhinovirus in respiratory tract infections in hospitalized children]‏
670 ‎‡a Author's Role of viral coinfections in asthma development.‏
670 ‎‡a Author's Spectrum of respiratory viruses in children with community-acquired pneumonia.‏
670 ‎‡a Author's Target-independent high-throughput sequencing methods provide evidence that already known human viral pathogens play a main role in respiratory infections with unexplained etiology‏
670 ‎‡a Author's Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene‏
670 ‎‡a Author's The burden of infections by parainfluenza virus in hospitalized children in Spain.‏
670 ‎‡a Author's The role of respiratory viruses in children with humoral immunodeficiency on immunoglobulin replacement therapy‏
670 ‎‡a Author's Thymic stromal lymphopoietin, IL-33, and periostin in hospitalized infants with viral bronchiolitis.‏
670 ‎‡a Author's Variability of influenza AH1N1 infections in a neonatal unit in Spain.‏
670 ‎‡a Author's [Viral respiratory tract infections in the Neonatal Intensive Care Unit].‏
909 ‎‡a (orcid) 0000000349064227‏ ‎‡9 1‏
919 ‎‡a variabilityofinfluenzaah1n1infectionsinaneonatalunitinspain‏ ‎‡A Variability of influenza AH1N1 infections in a neonatal unit in Spain.‏ ‎‡9 1‏
919 ‎‡a roleofrespiratoryvirusesinchildrenwithhumoralimmunodeficiencyonimmunoglobulinreplacementtherapy‏ ‎‡A The role of respiratory viruses in children with humoral immunodeficiency on immunoglobulin replacement therapy‏ ‎‡9 1‏
919 ‎‡a burdenofinfectionsbyparainfluenzavirusinhospitalizedchildreninspain‏ ‎‡A The burden of infections by parainfluenza virus in hospitalized children in Spain.‏ ‎‡9 1‏
919 ‎‡a 10yearsofglobalevolutionofthehumanrespiratorysyncytialvirusbagenotypewitha60nucleotideduplicationinthegproteingene‏ ‎‡A Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene‏ ‎‡9 1‏
919 ‎‡a targetindependenthighthroughputsequencingmethodsprovideevidencethatalreadyknownhumanviralpathogensplayamainroleinrespiratoryinfectionswithunexplainedetiology‏ ‎‡A Target-independent high-throughput sequencing methods provide evidence that already known human viral pathogens play a main role in respiratory infections with unexplained etiology‏ ‎‡9 1‏
919 ‎‡a spectrumofrespiratoryvirusesinchildrenwithcommunityacquiredpneumonia‏ ‎‡A Spectrum of respiratory viruses in children with community-acquired pneumonia.‏ ‎‡9 1‏
919 ‎‡a roleofviralcoinfectionsinasthmadevelopment‏ ‎‡A Role of viral coinfections in asthma development.‏ ‎‡9 1‏
919 ‎‡a roleofrhinovirusinrespiratorytractinfectionsinhospitalizedchildren‏ ‎‡A [Role of rhinovirus in respiratory tract infections in hospitalized children]‏ ‎‡9 1‏
919 ‎‡a roleofemergingrespiratoryvirusesinchildrenwithsevereacutewheezing‏ ‎‡A Role of emerging respiratory viruses in children with severe acute wheezing.‏ ‎‡9 1‏
919 ‎‡a respiratorysyncytialviruscoinfectionswithrhinovirusandhumanbocavirusinhospitalizedchildren‏ ‎‡A Respiratory Syncytial Virus Coinfections With Rhinovirus and Human Bocavirus in Hospitalized Children.‏ ‎‡9 1‏
919 ‎‡a respiratoryoutcomesofnewbronchopulmonarydysplasiainadolescentsamulticenterstudy‏ ‎‡A Respiratory outcomes of "new" bronchopulmonary dysplasia in adolescents: A multicenter study‏ ‎‡9 1‏
919 ‎‡a respiratorymorbidityassociatedwithviralrespiratoryinfectionsduringneonatalstageinprematureinfants‏ ‎‡A Respiratory morbidity associated with viral respiratory infections during neonatal stage in premature infants‏ ‎‡9 1‏
919 ‎‡a respiratoryinfectionsbyenterovirusd68inoutpatientsandinpatientsspanishchildren‏ ‎‡A Respiratory Infections by Enterovirus D68 in Outpatients and Inpatients Spanish Children‏ ‎‡9 1‏
919 ‎‡a replytoletterofdrscastrorodriguezandrodrigo‏ ‎‡A Reply to letter of Drs Castro-Rodriguez and Rodrigo.‏ ‎‡9 1‏
919 ‎‡a recurrentwheezingandasthmaafterbocavirusbronchiolitis‏ ‎‡A Recurrent wheezing and asthma after bocavirus bronchiolitis.‏ ‎‡9 1‏
919 ‎‡a radiografiadetoraxenlabronquiolitisessiemprenecesaria‏ ‎‡A Radiografía de tórax en la bronquiolitis: ¿es siempre necesaria?‏ ‎‡9 1‏
919 ‎‡a prospectivestudyofinfluenza100inhospitalizedchildren‏ ‎‡A Prospective study of influenza C in hospitalized children.‏ ‎‡9 1‏
919 ‎‡a pediatricasthmaandviralinfection‏ ‎‡A Pediatric Asthma and Viral Infection.‏ ‎‡9 1‏
919 ‎‡a parainfluenzavirustype4infections‏ ‎‡A [Parainfluenza virus type 4 infections]‏ ‎‡9 1‏
919 ‎‡a pandemich1n1influenzaassociatedhospitalizationsinchildreninmadridspain‏ ‎‡A Pandemic H1N1 influenza-associated hospitalizations in children in Madrid, Spain.‏ ‎‡9 1‏
919 ‎‡a oseltamivirtreatmentforinfluenzainhospitalizedchildrenwithoutunderlyingdiseases‏ ‎‡A Oseltamivir treatment for influenza in hospitalized children without underlying diseases.‏ ‎‡9 1‏
919 ‎‡a montelukastreducesasthmaexacerbationsin2to5yearoldchildrenwithintermittentasthma‏ ‎‡A Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma‏ ‎‡9 1‏
919 ‎‡a comparativestudyofinhaledciclesonide160microgdayandfluticasonepropionate176microgdayinchildrenwithasthma‏ ‎‡A A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma‏ ‎‡9 1‏
919 ‎‡a celiacdiseaseandglycogenosis‏ ‎‡A [Celiac disease and glycogenosis]‏ ‎‡9 1‏
919 ‎‡a clinicalandvirologicalcharacteristicsofearlyandmoderatepreterminfantsreadmittedwithviralrespiratoryinfections‏ ‎‡A Clinical and Virological Characteristics of Early and Moderate Preterm Infants Readmitted With Viral Respiratory Infections‏ ‎‡9 1‏
919 ‎‡a thymicstromallymphopoietinil33andperiostininhospitalizedinfantswithviralbronchiolitis‏ ‎‡A Thymic stromal lymphopoietin, IL-33, and periostin in hospitalized infants with viral bronchiolitis.‏ ‎‡9 1‏
919 ‎‡a clinicalcourseandanalysisofacaseofcongenitalchloridediarrhea‏ ‎‡A [Clinical course and analysis of a case of congenital chloride diarrhea]‏ ‎‡9 1‏
919 ‎‡a comparisonoftheefficacyandsafetyofciclesonide160microg11dailyvsbudesonide400microg11dailyinchildrenwithasthma‏ ‎‡A Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma‏ ‎‡9 1‏
919 ‎‡a considerationsonantiviraltreatmentofsuspectedinfluenzainfectionsinhospitalisedchildren‏ ‎‡A Considerations on antiviral treatment of suspected influenza infections in hospitalised children.‏ ‎‡9 1‏
919 ‎‡a diagnosisandtreatmentguidelinesfordifficulttocontrolasthmainchildren‏ ‎‡A [Diagnosis and treatment guidelines for difficult-to-control asthma in children]‏ ‎‡9 1‏
919 ‎‡a 8yearprospectivestudyofadenovirusesinfectionsinhospitalizedchildrencomparisonwithotherrespiratoryviruses‏ ‎‡A Eight Year Prospective Study of Adenoviruses Infections in Hospitalized Children. Comparison with Other Respiratory Viruses‏ ‎‡9 1‏
919 ‎‡a guidelinesforthefollowupofpatientswithbronchopulmonarydysplasia‏ ‎‡A [Guidelines for the follow up of patients with bronchopulmonary dysplasia]‏ ‎‡9 1‏
919 ‎‡a highincidenceofhumanbocavirusinfectioninchildreninspain‏ ‎‡A High incidence of human bocavirus infection in children in Spain.‏ ‎‡9 1‏
919 ‎‡a hospitaladmissionduetorespiratoryviralinfectionsinmoderatepretermlatepretermandterminfantsduringtheir1yearoflife‏ ‎‡A Hospital admission due to respiratory viral infections in moderate preterm, late preterm and term infants during their first year of life.‏ ‎‡9 1‏
919 ‎‡a humanbocavirusdetectioninnasopharyngealaspiratesofchildrenwithoutclinicalsymptomsofrespiratoryinfection‏ ‎‡A HUMAN BOCAVIRUS DETECTION IN NASOPHARYNGEAL ASPIRATES OF CHILDREN WITHOUT CLINICAL SYMPTOMS OF RESPIRATORY INFECTION‏ ‎‡9 1‏
919 ‎‡a humanbocavirusinfectioninaneonatalintensivecareunit‏ ‎‡A Human bocavirus infection in a neonatal intensive care unit‏ ‎‡9 1‏
919 ‎‡a humanmetapneumovirusbronchiolitisininfancyisanimportantriskfactorforasthmaatage5‏ ‎‡A Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5‏ ‎‡9 1‏
919 ‎‡a humanmetapneumovirusinfectionsinhospitalisedinfantsinspain‏ ‎‡A Human metapneumovirus infections in hospitalised infants in Spain.‏ ‎‡9 1‏
919 ‎‡a humanmetapnuemovirusinfectionsinhospitalizedchildrenandcomparisonwithotherrespiratoryviruses20052014prospectivestudy‏ ‎‡A Human metapnuemovirus infections in hospitalized children and comparison with other respiratory viruses. 2005-2014 prospective study‏ ‎‡9 1‏
919 ‎‡a humanparechovirus3infectioninaneonatewithfeverandsuspectedsepsis‏ ‎‡A [Human parechovirus-3 infection in a neonate with fever and suspected sepsis].‏ ‎‡9 1‏
919 ‎‡a impactofprematurityandsevereviralbronchiolitisonasthmadevelopmentat69years‏ ‎‡A Impact of Prematurity and Severe Viral Bronchiolitis on Asthma Development at 6-9 Years‏ ‎‡9 1‏
919 ‎‡a infeccionesrespiratoriaspormetapneumovirusenlactanteshospitalizados‏ ‎‡A Infecciones respiratorias por metapneumovirus en lactantes hospitalizados‏ ‎‡9 1‏
919 ‎‡a infeccionesviralesrespiratoriasenunacohortedeninosduranteel1anodevidaysupapeleneldesarrollodesibilancias‏ ‎‡A Infecciones virales respiratorias en una cohorte de niños durante el primer año de vida y su papel en el desarrollo de sibilancias‏ ‎‡9 1‏
919 ‎‡a infectionsandcoinfectionsbyrespiratoryhumanbocavirusduring8seasonsinhospitalizedchildren‏ ‎‡A Infections and coinfections by respiratory human bocavirus during eight seasons in hospitalized children.‏ ‎‡9 1‏
919 ‎‡a influenza100virusinfectioninchildrenspain‏ ‎‡A Influenza C virus infection in children, Spain.‏ ‎‡9 1‏
919 ‎‡a influenzavirusinfectionsininfantsagedlessthan2yearsold‏ ‎‡A [Influenza virus infections in infants aged less than two years old]‏ ‎‡9 1‏
919 ‎‡a viralrespiratorytractinfectionsintheneonatalintensivecareunit‏ ‎‡A [Viral respiratory tract infections in the Neonatal Intensive Care Unit].‏ ‎‡9 1‏
996 ‎‡2 B2Q|0000862156‏
996 ‎‡2 DNB|171362799‏
996 ‎‡2 BNE|XX1279716‏
996 ‎‡2 LC|n 2022025940‏
996 ‎‡2 BNC|981058516153106706‏
996 ‎‡2 BNC|981058580293406706‏
996 ‎‡2 ISNI|0000000506744382‏
996 ‎‡2 ISNI|0000000060452747‏
996 ‎‡2 BNE|XX1101567‏
996 ‎‡2 BNC|981058610462506706‏
996 ‎‡2 SUDOC|250800845‏
996 ‎‡2 NII|DA09109031‏
996 ‎‡2 BNE|XX1554159‏
996 ‎‡2 BNF|15007424‏
996 ‎‡2 BIBSYS|3033514‏
996 ‎‡2 PTBNP|1546828‏
996 ‎‡2 BNE|XX1026516‏
996 ‎‡2 RERO|A013229577‏
996 ‎‡2 LC|no2019104409‏
996 ‎‡2 BNE|XX5490051‏
996 ‎‡2 LC|n 94050983‏
996 ‎‡2 PTBNP|79133‏
996 ‎‡2 BNE|XX1168168‏
996 ‎‡2 SUDOC|138937478‏
996 ‎‡2 SUDOC|149310900‏
996 ‎‡2 DNB|1080932313‏
996 ‎‡2 ISNI|0000000036264295‏
996 ‎‡2 SUDOC|117622958‏
996 ‎‡2 ISNI|0000000380696652‏
996 ‎‡2 BNE|XX821592‏
996 ‎‡2 LC|n 92075402‏
996 ‎‡2 SUDOC|170045005‏
996 ‎‡2 ISNI|0000000059376177‏
996 ‎‡2 LC|n 90674836‏
996 ‎‡2 ISNI|0000000059317943‏
996 ‎‡2 LC|nr 95031051‏
996 ‎‡2 BNE|XX5618003‏
996 ‎‡2 DNB|1079630740‏
996 ‎‡2 ISNI|0000000040044076‏
996 ‎‡2 LC|nr 92014039‏
996 ‎‡2 SUDOC|034234098‏
996 ‎‡2 PLWABN|9810948358405606‏
996 ‎‡2 BNF|16260071‏
996 ‎‡2 ISNI|0000000060226168‏
996 ‎‡2 ISNI|0000000046491803‏
996 ‎‡2 LC|n 94068391‏
996 ‎‡2 LC|no2008165135‏
996 ‎‡2 LC|n 2022016138‏
996 ‎‡2 DNB|1057558745‏
996 ‎‡2 ISNI|0000000354435299‏
996 ‎‡2 PTBNP|254657‏
996 ‎‡2 DNB|1074665511‏
996 ‎‡2 BNC|981058516075806706‏
996 ‎‡2 ISNI|000000006639607X‏
996 ‎‡2 ISNI|0000000118813112‏
996 ‎‡2 BNC|981060888560606706‏
996 ‎‡2 BNE|XX5417358‏
996 ‎‡2 BNE|XX880910‏
996 ‎‡2 J9U|987007592497505171‏
996 ‎‡2 ISNI|0000000019471778‏
996 ‎‡2 SUDOC|25269029X‏
996 ‎‡2 BNE|XX1734804‏
996 ‎‡2 NTA|240046749‏
996 ‎‡2 BNE|XX1343583‏
996 ‎‡2 BNE|XX939772‏
996 ‎‡2 DNB|188481672‏
996 ‎‡2 BNE|XX834598‏
996 ‎‡2 ISNI|000000007023273X‏
996 ‎‡2 BNE|XX1597714‏
996 ‎‡2 ISNI|0000000059311816‏
996 ‎‡2 DNB|1056734000‏
996 ‎‡2 BNF|17815981‏
996 ‎‡2 ISNI|0000000356260744‏
996 ‎‡2 LC|ns2016003002‏
996 ‎‡2 BNF|16144476‏
996 ‎‡2 SUDOC|270131280‏
996 ‎‡2 LC|no2002083613‏
996 ‎‡2 ISNI|0000000450513322‏
996 ‎‡2 ISNI|0000000059987760‏
996 ‎‡2 NUKAT|n 2003060315‏
996 ‎‡2 ISNI|0000000001987776‏
996 ‎‡2 BNC|981058525096506706‏
996 ‎‡2 SUDOC|05710400X‏
996 ‎‡2 ISNI|000000004656972X‏
996 ‎‡2 J9U|987007276279405171‏
996 ‎‡2 DNB|1157411959‏
996 ‎‡2 BNF|12460619‏
996 ‎‡2 BNE|XX5674770‏
996 ‎‡2 BNF|13476625‏
996 ‎‡2 DNB|141123842‏
996 ‎‡2 BNC|981058515988806706‏
996 ‎‡2 BNE|XX1393761‏
996 ‎‡2 LC|n 2006184411‏
996 ‎‡2 LC|no2013119984‏
996 ‎‡2 DNB|1304905349‏
996 ‎‡2 LC|no2007158873‏
996 ‎‡2 LC|no2019031205‏
996 ‎‡2 ISNI|0000000060907473‏
996 ‎‡2 SUDOC|147927250‏
996 ‎‡2 DNB|1343135141‏
996 ‎‡2 LC|no2022106463‏
996 ‎‡2 BNE|XX6467249‏
996 ‎‡2 BNC|981058616368406706‏
996 ‎‡2 LC|nr 94006549‏
996 ‎‡2 ISNI|0000000079764476‏
996 ‎‡2 BNC|981058511183006706‏
996 ‎‡2 LC|n 82038287‏
996 ‎‡2 DNB|124840922‏
996 ‎‡2 ISNI|0000000049966077‏
996 ‎‡2 PTBNP|1535939‏
996 ‎‡2 LC|no2010076443‏
996 ‎‡2 ISNI|0000000383830335‏
996 ‎‡2 LC|n 84155355‏
996 ‎‡2 ISNI|0000000064398610‏
996 ‎‡2 W2Z|9015740‏
996 ‎‡2 NII|DA16271197‏
996 ‎‡2 BNC|981058518088506706‏
996 ‎‡2 LC|n 2005055992‏
996 ‎‡2 LC|n 2018185962‏
996 ‎‡2 LC|n 78028587‏
996 ‎‡2 LC|n 2020033077‏
996 ‎‡2 LC|no2008077996‏
996 ‎‡2 LC|ns2018002319‏
996 ‎‡2 LC|n 2017035655‏
996 ‎‡2 ISNI|0000000060295841‏
996 ‎‡2 LC|nr 94017717‏
996 ‎‡2 LC|n 2008005183‏
996 ‎‡2 CAOONL|ncf10326153‏
996 ‎‡2 BNE|XX1095833‏
996 ‎‡2 BNE|XX1310152‏
996 ‎‡2 BNE|XX961082‏
996 ‎‡2 DNB|1056444878‏
996 ‎‡2 RERO|A006362372‏
996 ‎‡2 ISNI|0000000081614143‏
996 ‎‡2 DNB|1115278290‏
996 ‎‡2 LC|no2008058785‏
996 ‎‡2 ISNI|0000000066367797‏
996 ‎‡2 LC|n 85380550‏
996 ‎‡2 BNE|XX1282349‏
996 ‎‡2 SUDOC|168355167‏
996 ‎‡2 ISNI|0000000071414762‏
996 ‎‡2 CAOONL|ncf11376711‏
996 ‎‡2 NYNYRILM|384211‏
996 ‎‡2 BNF|11885584‏
996 ‎‡2 LC|no 97028643‏
996 ‎‡2 BNE|XX950723‏
996 ‎‡2 BNE|XX950722‏
996 ‎‡2 ISNI|0000000066363833‏
996 ‎‡2 ISNI|0000000067535617‏
996 ‎‡2 SUDOC|085799602‏
996 ‎‡2 BNE|XX5898596‏
996 ‎‡2 BNF|14526339‏
996 ‎‡2 LC|no2007057731‏
996 ‎‡2 BNE|XX867525‏
996 ‎‡2 BNE|XX885537‏
996 ‎‡2 PTBNP|263602‏
996 ‎‡2 ISNI|0000000048426204‏
996 ‎‡2 DNB|1035572702‏
996 ‎‡2 BNC|981058516314006706‏
996 ‎‡2 NUKAT|n 2009146582‏
996 ‎‡2 SUDOC|170551830‏
996 ‎‡2 BNE|XX1741747‏
996 ‎‡2 SUDOC|063464314‏
996 ‎‡2 ISNI|0000000079704756‏
996 ‎‡2 LC|no2009159394‏
996 ‎‡2 ISNI|0000000115571453‏
996 ‎‡2 BNE|XX1224382‏
996 ‎‡2 LC|no2021073341‏
996 ‎‡2 BNC|981058510154506706‏
996 ‎‡2 SUDOC|14015762X‏
996 ‎‡2 B2Q|0000772712‏
996 ‎‡2 LC|no2009096201‏
996 ‎‡2 NUKAT|n 2016054369‏
996 ‎‡2 BLBNB|000215078‏
996 ‎‡2 LC|ns2024002444‏
996 ‎‡2 DNB|1038158761‏
996 ‎‡2 BNE|XX1081760‏
996 ‎‡2 LC|n 2017251616‏
996 ‎‡2 LC|n 80098304‏
996 ‎‡2 BNE|XX854760‏
996 ‎‡2 SUDOC|195145941‏
996 ‎‡2 ISNI|0000000060503911‏
996 ‎‡2 BNF|15569921‏
996 ‎‡2 DNB|1057280798‏
996 ‎‡2 DNB|124546597X‏
996 ‎‡2 LC|n 94116053‏
996 ‎‡2 NTA|27974952X‏
996 ‎‡2 SELIBR|222039‏
996 ‎‡2 RERO|A027591050‏
996 ‎‡2 SIMACOB|35608163‏
996 ‎‡2 DNB|1048248135‏
996 ‎‡2 PTBNP|1309842‏
996 ‎‡2 J9U|987007440820105171‏
996 ‎‡2 DNB|1074373324‏
996 ‎‡2 B2Q|0001195271‏
996 ‎‡2 LC|no2021034371‏
996 ‎‡2 BNE|XX993034‏
996 ‎‡2 PTBNP|1488463‏
996 ‎‡2 BNE|XX957843‏
996 ‎‡2 DNB|105738481X‏
996 ‎‡2 BNE|XX922445‏
996 ‎‡2 BNC|981058529856206706‏
996 ‎‡2 ISNI|0000000044763588‏
996 ‎‡2 LC|n 85306757‏
996 ‎‡2 LC|ns2012000155‏
996 ‎‡2 ISNI|0000000021672720‏
996 ‎‡2 DNB|138316597‏
996 ‎‡2 NUKAT|n 2020029416‏
996 ‎‡2 ISNI|0000000357034052‏
996 ‎‡2 LC|n 2021048953‏
996 ‎‡2 LC|no2001031475‏
996 ‎‡2 LC|n 2001088748‏
996 ‎‡2 BNE|XX1167773‏
996 ‎‡2 ISNI|0000000083731941‏
996 ‎‡2 SUDOC|243167296‏
996 ‎‡2 ISNI|0000000111037544‏
996 ‎‡2 BNF|12239675‏
996 ‎‡2 ISNI|0000000454881739‏
996 ‎‡2 BLBNB|000268815‏
996 ‎‡2 ISNI|0000000059530007‏
996 ‎‡2 BNC|981058516784606706‏
996 ‎‡2 LC|nr2007002222‏
996 ‎‡2 BNE|XX872274‏
996 ‎‡2 LC|n 2008217204‏
996 ‎‡2 BNC|981058604779406706‏
996 ‎‡2 BNE|XX899830‏
996 ‎‡2 BNE|XX1272702‏
996 ‎‡2 ISNI|0000000476678897‏
996 ‎‡2 SUDOC|083843051‏
996 ‎‡2 BNCHL|10000000000000000044141‏
996 ‎‡2 NUKAT|n 2022034312‏
996 ‎‡2 ISNI|0000000079149924‏
996 ‎‡2 BNE|XX5050356‏
996 ‎‡2 LC|no2023094361‏
996 ‎‡2 SUDOC|033755256‏
996 ‎‡2 ISNI|0000000059339368‏
996 ‎‡2 BNE|XX1470354‏
996 ‎‡2 ISNI|0000000116585582‏
996 ‎‡2 SUDOC|144196395‏
996 ‎‡2 BNE|XX6104650‏
996 ‎‡2 BNE|XX1037356‏
996 ‎‡2 BNE|XX1053806‏
996 ‎‡2 BNE|XX1082175‏
996 ‎‡2 LC|n 83205137‏
996 ‎‡2 CAOONL|ncf10897137‏
996 ‎‡2 DNB|1016243251‏
996 ‎‡2 BNE|XX5409228‏
996 ‎‡2 BIBSYS|90705046‏
996 ‎‡2 BNE|XX5589470‏
996 ‎‡2 LC|no2020067701‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏